Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study

Purpose: Assess the quality of life impact of receiving indeterminate test results for hemochromatosis, a disorder involving HFE genetic mutations and/or elevated serum transferrin saturation and ferritin. Methods: The study sample was from the Hemochromatosis and Iron Overload Screening Study, a la...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genetics in medicine 2006-11, Vol.8 (11), p.681-687
Hauptverfasser: Anderson, Roger T., Wenzel, Lari, Walker, Ann P., Ruggiero, Andrea, Acton, Ronald T., Hall, Mark A., Tucker, Diane C., Thomson, Elizabeth, Harrison, Barbara, Howe, Edmund, Holup, Joan, Leiendecker-Foster, Catherine, Power, Tara, Adams, Paul
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 687
container_issue 11
container_start_page 681
container_title Genetics in medicine
container_volume 8
creator Anderson, Roger T.
Wenzel, Lari
Walker, Ann P.
Ruggiero, Andrea
Acton, Ronald T.
Hall, Mark A.
Tucker, Diane C.
Thomson, Elizabeth
Harrison, Barbara
Howe, Edmund
Holup, Joan
Leiendecker-Foster, Catherine
Power, Tara
Adams, Paul
description Purpose: Assess the quality of life impact of receiving indeterminate test results for hemochromatosis, a disorder involving HFE genetic mutations and/or elevated serum transferrin saturation and ferritin. Methods: The study sample was from the Hemochromatosis and Iron Overload Screening Study, a large observational study of hemochromatosis among primary care patients in the US and Canada using HFE genotype and serum transferrin saturation and ferritin screening. Study subjects included 2,304 patients found with hemochromatosis risk of uncertain clinical significance. Assessed was SF-36 general health and emotional well-being before screening and six weeks after participants received their test results. Health worries were assessed after screening. Results: Of the study subjects, 1,268 participants (51.5%) completed both assessments. Compared to normal controls, those with HFE mutations or elevated serum transferrin saturation and ferritin levels of uncertain significance were more likely to report diminished general health and mental well-being, and more health worries. These effects were associated with participants' belief of having tested positive for hemochromatosis or iron overload. Conclusion: Notification of indeterminate results from screening may be associated with mild negative effects on well-being, and might be a potential participant risk in screening programs for disorders with uncertain genotype-phenotype.
doi_str_mv 10.1097/01.gim.0000245631.07117.ac
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68152232</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1098360021034717</els_id><sourcerecordid>19723128</sourcerecordid><originalsourceid>FETCH-LOGICAL-c461t-68e82f428d2f67d1dfc041bb081bb888416bf755c972c94b4602709f7ca4f8353</originalsourceid><addsrcrecordid>eNqNkcFu1TAQRSMEoqXwC8hiwS5hxklspztUWqhUiU1ZW4496TNK4oftFHXJn2N4TyoSC_DCtqwz90o-VfUGoUEY5DvA5s4vDZTFu1602IBElI2xT6pT7FuooRXiabnDoOpWAJxUL1L6CoCy5fC8OkGJoGQ_nFY_rpe9sZmFie1oCXYXw2JySD6xZCPR6tc75le2N9nTmhP77vOuPDjKFBe_mkwsUtrmnM7Z7Y7-SjGrYz6GlYV7inMw7o_clDf38LJ6Npk50avjeVZ9ubq8vfhU33z-eH3x_qa2ncBcC0WKTx1Xjk9COnSThQ7HEVTZlFIdinGSfW8Hye3QjZ0ALmGYpDXdpNq-PaveHnL3MXzbKGW9-GRpns1KYUtaKOw5b_k_QSwNLXJVwPMDaGNIKdKk99EvJj5oBP3LlAbUxZR-NKV_m9LGluHXx5ZtXMg9jh7VFODDAaDyKfeeok62KLDkfCSbtQv-f3p-Ao7jqX4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19723128</pqid></control><display><type>article</type><title>Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>ProQuest Central UK/Ireland</source><source>Alma/SFX Local Collection</source><creator>Anderson, Roger T. ; Wenzel, Lari ; Walker, Ann P. ; Ruggiero, Andrea ; Acton, Ronald T. ; Hall, Mark A. ; Tucker, Diane C. ; Thomson, Elizabeth ; Harrison, Barbara ; Howe, Edmund ; Holup, Joan ; Leiendecker-Foster, Catherine ; Power, Tara ; Adams, Paul</creator><creatorcontrib>Anderson, Roger T. ; Wenzel, Lari ; Walker, Ann P. ; Ruggiero, Andrea ; Acton, Ronald T. ; Hall, Mark A. ; Tucker, Diane C. ; Thomson, Elizabeth ; Harrison, Barbara ; Howe, Edmund ; Holup, Joan ; Leiendecker-Foster, Catherine ; Power, Tara ; Adams, Paul</creatorcontrib><description>Purpose: Assess the quality of life impact of receiving indeterminate test results for hemochromatosis, a disorder involving HFE genetic mutations and/or elevated serum transferrin saturation and ferritin. Methods: The study sample was from the Hemochromatosis and Iron Overload Screening Study, a large observational study of hemochromatosis among primary care patients in the US and Canada using HFE genotype and serum transferrin saturation and ferritin screening. Study subjects included 2,304 patients found with hemochromatosis risk of uncertain clinical significance. Assessed was SF-36 general health and emotional well-being before screening and six weeks after participants received their test results. Health worries were assessed after screening. Results: Of the study subjects, 1,268 participants (51.5%) completed both assessments. Compared to normal controls, those with HFE mutations or elevated serum transferrin saturation and ferritin levels of uncertain significance were more likely to report diminished general health and mental well-being, and more health worries. These effects were associated with participants' belief of having tested positive for hemochromatosis or iron overload. Conclusion: Notification of indeterminate results from screening may be associated with mild negative effects on well-being, and might be a potential participant risk in screening programs for disorders with uncertain genotype-phenotype.</description><identifier>ISSN: 1098-3600</identifier><identifier>EISSN: 1530-0366</identifier><identifier>DOI: 10.1097/01.gim.0000245631.07117.ac</identifier><identifier>PMID: 17108759</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>acceptance ; Adult ; Aged ; Attitude to Health ; ethics ; Ethnicity ; Female ; Genetic Testing - psychology ; HEIRS ; Hemochromatosis ; Hemochromatosis - genetics ; Hemochromatosis - psychology ; Humans ; Iron Overload - diagnosis ; Male ; Middle Aged ; Mutation ; primary care ; Quality of Life ; screening ; Social Class</subject><ispartof>Genetics in medicine, 2006-11, Vol.8 (11), p.681-687</ispartof><rights>2006 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c461t-68e82f428d2f67d1dfc041bb081bb888416bf755c972c94b4602709f7ca4f8353</citedby><cites>FETCH-LOGICAL-c461t-68e82f428d2f67d1dfc041bb081bb888416bf755c972c94b4602709f7ca4f8353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906,64366</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17108759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anderson, Roger T.</creatorcontrib><creatorcontrib>Wenzel, Lari</creatorcontrib><creatorcontrib>Walker, Ann P.</creatorcontrib><creatorcontrib>Ruggiero, Andrea</creatorcontrib><creatorcontrib>Acton, Ronald T.</creatorcontrib><creatorcontrib>Hall, Mark A.</creatorcontrib><creatorcontrib>Tucker, Diane C.</creatorcontrib><creatorcontrib>Thomson, Elizabeth</creatorcontrib><creatorcontrib>Harrison, Barbara</creatorcontrib><creatorcontrib>Howe, Edmund</creatorcontrib><creatorcontrib>Holup, Joan</creatorcontrib><creatorcontrib>Leiendecker-Foster, Catherine</creatorcontrib><creatorcontrib>Power, Tara</creatorcontrib><creatorcontrib>Adams, Paul</creatorcontrib><title>Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study</title><title>Genetics in medicine</title><addtitle>Genet Med</addtitle><description>Purpose: Assess the quality of life impact of receiving indeterminate test results for hemochromatosis, a disorder involving HFE genetic mutations and/or elevated serum transferrin saturation and ferritin. Methods: The study sample was from the Hemochromatosis and Iron Overload Screening Study, a large observational study of hemochromatosis among primary care patients in the US and Canada using HFE genotype and serum transferrin saturation and ferritin screening. Study subjects included 2,304 patients found with hemochromatosis risk of uncertain clinical significance. Assessed was SF-36 general health and emotional well-being before screening and six weeks after participants received their test results. Health worries were assessed after screening. Results: Of the study subjects, 1,268 participants (51.5%) completed both assessments. Compared to normal controls, those with HFE mutations or elevated serum transferrin saturation and ferritin levels of uncertain significance were more likely to report diminished general health and mental well-being, and more health worries. These effects were associated with participants' belief of having tested positive for hemochromatosis or iron overload. Conclusion: Notification of indeterminate results from screening may be associated with mild negative effects on well-being, and might be a potential participant risk in screening programs for disorders with uncertain genotype-phenotype.</description><subject>acceptance</subject><subject>Adult</subject><subject>Aged</subject><subject>Attitude to Health</subject><subject>ethics</subject><subject>Ethnicity</subject><subject>Female</subject><subject>Genetic Testing - psychology</subject><subject>HEIRS</subject><subject>Hemochromatosis</subject><subject>Hemochromatosis - genetics</subject><subject>Hemochromatosis - psychology</subject><subject>Humans</subject><subject>Iron Overload - diagnosis</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>primary care</subject><subject>Quality of Life</subject><subject>screening</subject><subject>Social Class</subject><issn>1098-3600</issn><issn>1530-0366</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1TAQRSMEoqXwC8hiwS5hxklspztUWqhUiU1ZW4496TNK4oftFHXJn2N4TyoSC_DCtqwz90o-VfUGoUEY5DvA5s4vDZTFu1602IBElI2xT6pT7FuooRXiabnDoOpWAJxUL1L6CoCy5fC8OkGJoGQ_nFY_rpe9sZmFie1oCXYXw2JySD6xZCPR6tc75le2N9nTmhP77vOuPDjKFBe_mkwsUtrmnM7Z7Y7-SjGrYz6GlYV7inMw7o_clDf38LJ6Npk50avjeVZ9ubq8vfhU33z-eH3x_qa2ncBcC0WKTx1Xjk9COnSThQ7HEVTZlFIdinGSfW8Hye3QjZ0ALmGYpDXdpNq-PaveHnL3MXzbKGW9-GRpns1KYUtaKOw5b_k_QSwNLXJVwPMDaGNIKdKk99EvJj5oBP3LlAbUxZR-NKV_m9LGluHXx5ZtXMg9jh7VFODDAaDyKfeeok62KLDkfCSbtQv-f3p-Ao7jqX4</recordid><startdate>200611</startdate><enddate>200611</enddate><creator>Anderson, Roger T.</creator><creator>Wenzel, Lari</creator><creator>Walker, Ann P.</creator><creator>Ruggiero, Andrea</creator><creator>Acton, Ronald T.</creator><creator>Hall, Mark A.</creator><creator>Tucker, Diane C.</creator><creator>Thomson, Elizabeth</creator><creator>Harrison, Barbara</creator><creator>Howe, Edmund</creator><creator>Holup, Joan</creator><creator>Leiendecker-Foster, Catherine</creator><creator>Power, Tara</creator><creator>Adams, Paul</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>200611</creationdate><title>Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study</title><author>Anderson, Roger T. ; Wenzel, Lari ; Walker, Ann P. ; Ruggiero, Andrea ; Acton, Ronald T. ; Hall, Mark A. ; Tucker, Diane C. ; Thomson, Elizabeth ; Harrison, Barbara ; Howe, Edmund ; Holup, Joan ; Leiendecker-Foster, Catherine ; Power, Tara ; Adams, Paul</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c461t-68e82f428d2f67d1dfc041bb081bb888416bf755c972c94b4602709f7ca4f8353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>acceptance</topic><topic>Adult</topic><topic>Aged</topic><topic>Attitude to Health</topic><topic>ethics</topic><topic>Ethnicity</topic><topic>Female</topic><topic>Genetic Testing - psychology</topic><topic>HEIRS</topic><topic>Hemochromatosis</topic><topic>Hemochromatosis - genetics</topic><topic>Hemochromatosis - psychology</topic><topic>Humans</topic><topic>Iron Overload - diagnosis</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>primary care</topic><topic>Quality of Life</topic><topic>screening</topic><topic>Social Class</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anderson, Roger T.</creatorcontrib><creatorcontrib>Wenzel, Lari</creatorcontrib><creatorcontrib>Walker, Ann P.</creatorcontrib><creatorcontrib>Ruggiero, Andrea</creatorcontrib><creatorcontrib>Acton, Ronald T.</creatorcontrib><creatorcontrib>Hall, Mark A.</creatorcontrib><creatorcontrib>Tucker, Diane C.</creatorcontrib><creatorcontrib>Thomson, Elizabeth</creatorcontrib><creatorcontrib>Harrison, Barbara</creatorcontrib><creatorcontrib>Howe, Edmund</creatorcontrib><creatorcontrib>Holup, Joan</creatorcontrib><creatorcontrib>Leiendecker-Foster, Catherine</creatorcontrib><creatorcontrib>Power, Tara</creatorcontrib><creatorcontrib>Adams, Paul</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Genetics in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anderson, Roger T.</au><au>Wenzel, Lari</au><au>Walker, Ann P.</au><au>Ruggiero, Andrea</au><au>Acton, Ronald T.</au><au>Hall, Mark A.</au><au>Tucker, Diane C.</au><au>Thomson, Elizabeth</au><au>Harrison, Barbara</au><au>Howe, Edmund</au><au>Holup, Joan</au><au>Leiendecker-Foster, Catherine</au><au>Power, Tara</au><au>Adams, Paul</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study</atitle><jtitle>Genetics in medicine</jtitle><addtitle>Genet Med</addtitle><date>2006-11</date><risdate>2006</risdate><volume>8</volume><issue>11</issue><spage>681</spage><epage>687</epage><pages>681-687</pages><issn>1098-3600</issn><eissn>1530-0366</eissn><abstract>Purpose: Assess the quality of life impact of receiving indeterminate test results for hemochromatosis, a disorder involving HFE genetic mutations and/or elevated serum transferrin saturation and ferritin. Methods: The study sample was from the Hemochromatosis and Iron Overload Screening Study, a large observational study of hemochromatosis among primary care patients in the US and Canada using HFE genotype and serum transferrin saturation and ferritin screening. Study subjects included 2,304 patients found with hemochromatosis risk of uncertain clinical significance. Assessed was SF-36 general health and emotional well-being before screening and six weeks after participants received their test results. Health worries were assessed after screening. Results: Of the study subjects, 1,268 participants (51.5%) completed both assessments. Compared to normal controls, those with HFE mutations or elevated serum transferrin saturation and ferritin levels of uncertain significance were more likely to report diminished general health and mental well-being, and more health worries. These effects were associated with participants' belief of having tested positive for hemochromatosis or iron overload. Conclusion: Notification of indeterminate results from screening may be associated with mild negative effects on well-being, and might be a potential participant risk in screening programs for disorders with uncertain genotype-phenotype.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17108759</pmid><doi>10.1097/01.gim.0000245631.07117.ac</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1098-3600
ispartof Genetics in medicine, 2006-11, Vol.8 (11), p.681-687
issn 1098-3600
1530-0366
language eng
recordid cdi_proquest_miscellaneous_68152232
source MEDLINE; EZB-FREE-00999 freely available EZB journals; ProQuest Central UK/Ireland; Alma/SFX Local Collection
subjects acceptance
Adult
Aged
Attitude to Health
ethics
Ethnicity
Female
Genetic Testing - psychology
HEIRS
Hemochromatosis
Hemochromatosis - genetics
Hemochromatosis - psychology
Humans
Iron Overload - diagnosis
Male
Middle Aged
Mutation
primary care
Quality of Life
screening
Social Class
title Impact of hemochromatosis screening in patients with indeterminate results: The hemochromatosis and iron overload screening study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T08%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20hemochromatosis%20screening%20in%20patients%20with%20indeterminate%20results:%20The%20hemochromatosis%20and%20iron%20overload%20screening%20study&rft.jtitle=Genetics%20in%20medicine&rft.au=Anderson,%20Roger%20T.&rft.date=2006-11&rft.volume=8&rft.issue=11&rft.spage=681&rft.epage=687&rft.pages=681-687&rft.issn=1098-3600&rft.eissn=1530-0366&rft_id=info:doi/10.1097/01.gim.0000245631.07117.ac&rft_dat=%3Cproquest_cross%3E19723128%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19723128&rft_id=info:pmid/17108759&rft_els_id=S1098360021034717&rfr_iscdi=true